Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AS1402 plus Letrozole in Advanced Breast Cancer
NCT00770354Phase 2Terminated
- Sponsor
- Antisoma
- Start
- Sep 2008
- Primary completion
- Aug 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bth1704 in breast cancer, sponsored by Antisoma. Started Sep 2008; status: terminated.
02
Drugs
bth1704
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00770354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00770354.